Research funder · United States
Melanoma Research Alliance
Nonprofit organization in Washington D.C., United States
- Grants since 2016
- 400
- Awarded, last 5 years (where amounts are published)
- 72.1M
- Funded works, last 5 years
- 1 190
- Funded works, all time
- 2 826
Grants
2025–2028 · award
Treating Melanoma Brain Metastasis using Bispecific CAR Gamma Delta T cells
Xiaowei Xu · University of Pennsylvania
2025–2026 · award
Melanoma Prognostication Using Integrated Digital Pathology and Genomics
David Liu · Dana-Farber Cancer Institute
2025–2028 · award
mIF biomarker assay to predict response to anti-PD-1 mono vs. combo therapy
Janis Taube · Johns Hopkins University
2025–2028 · award
Harnessing nutrition to enhance melanoma-specific T cells
Nicholas Collins · Weill Cornell Medicine
2025–2028 · award
Interrupting Melanoma Leptomeningeal Metastasis
Adrienne Boire · Memorial Sloan Kettering Cancer Center
2025–2027 · award
Characterizing dormant uveal melanoma cells from clinical biopsies
Rizwan Haq · Dana-Farber Cancer Institute
2025–2028 · award
Epigenetic control of melanoma inflammatory CAFs
Emily Bernstein · Icahn School of Medicine at Mount Sinai
2025–2027 · award
Microproteins as Biomarkers in Melanoma
Sarah Slavoff · Yale University
2025–2026 · award
Characterization of Recently Established Acral Melanoma Mouse Models
Sheri Holmen · University of Utah
2025–2030 · award
Rare Melanoma Consortium: Thomas Jefferson University
Andrew Aplin · Thomas Jefferson University
2025–2028 · award
Nanoparticle reprogramming of antigen presentation for acral melanoma
Joel Sunshine · Johns Hopkins University
2025–2027 · award
Development of a drug repurposing pipeline for rare melanoma
John Lamar · Albany Medical College
2025–2027 · award
Developing INPP5A inhibitors to target all GNAQ/11 mutated uveal melanoma
Mitchell Levesque · University of Zurich
2025–2027 · award
Publicly-available database and resources for melanoma biomarker discovery
Janis Taube · Johns Hopkins University
2025–2028 · award
Identifying and targeting immunotherapy tolerance mechanisms in melanoma
Claudia Capparelli · Thomas Jefferson University
2025–2027 · award
Advancing Next-Generation CAR-T Cell Therapy for Acral and Uveal Melanoma
Cristina Puig Saus · The Regents Of The University Of California, Los Angeles
2025–2028 · award
Epigenetic editing to improve melanoma TIL therapy
Kunal Rai · The University of Texas MD Anderson Cancer Center
2025–2028 · award
Modeling Primary GNAQ/BAP1-driven Uveal Melanoma in Zebrafish
Colin Kenny · University of Iowa
2025–2027 · award
Engineering B cells for adoptive therapy against acral melanoma
Bin Zhang · Northwestern University
2025–2030 · award
Rare Melanoma Consortium: University of Colorado Denver
Kasey Couts · University Of Colorado Denver, Amc And Dc
2025–2027 · award
Characterization of Rare Uveal Melanoma Preclinical Models
Zelia Correa · University of Miami
2025–2028 · award
Stress-induced immune dysregulation as a driver of immunotherapy resistance
Christian Blank · Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis (the Netherlands Cancer Institute - Nki)
2025–2027 · award
Aqueous Humor liquid biopsy biomarker exploration in uveal melanoma
Jesse Berry · Children's Hospital of Los Angeles
2025–2027 · award
Galectin-targeted immunotherapy: transforming melanoma treatment
Laia Querol Cano · Radboud University Medical Center
2025–2028 · award
Targeting myeloid cells of the tumor microenvironment
Jennifer Yunyan Zhang · Duke University
2025–2028 · award
Epigenetic regulation of IL-7 to enhance cell therapies for melanoma
Goran Micevic · Yale University
2025–2028 · award
Targeting SIRT5 in uveal melanoma
David Lombard · University of Miami
2025–2030 · award
Rare Melanoma Consortium: Moffitt Cancer Center
Keiran Smalley · Moffitt Cancer Center
2025–2028 · award
The axes of acral melanoma - anatomic position and driver oncogenes
Richard White · University of Oxford
2025–2028 · award
Neoadjuvant research platform to personalize therapy for melanoma patients.
Ines Silva · Melanoma Institute Australia
2025–2028 · award
The aging brain microenvironment promotes brain metastases
Ashani Weeraratna · Johns Hopkins University Applied Physics Laboratory
2025–2028 · award
Rewiring exhausted T cell-derived chemokines to improve anti-tumor immunity
Kelly Kersten · Sanford Burnham Prebys Medical Discovery Institute
2025–2026 · award
Novel therapies for uveal melanomas
Aashish Manglik · Regent University
2025–2027 · award
Characterizing Novel, Personalized Translational Models of Uveal Melanoma
Lauren Dalvin · Mayo Clinic
2025–2028 · award
Deciphering T cell determinants of resistance to neoadjuvant immunotherapy
Giacomo Oliveira · Dana-Farber Cancer Institute
2025–2027 · award
Paralog-selective TEAD inhibitors in acral and uveal melanoma
Andrew Aplin · Thomas Jefferson University
2025–2028 · award
Clinical utility of mitochondrial genetics in ICI efficacy prediction.
Tomas Kirchhoff · New York University
2025–2028 · award
Early Spread and Immune Responses in Pediatric Spitz Tumors
Boris Bastian · Regent University
2025–2028 · award
PREMIER Project in Melanoma
Sapna Patel · University Of Colorado Denver, Amc And Dc
2024–2026 · award
CARkines: A path towards the next generation of T cell therapies
Cristina Puig Saus · The Regents Of The University Of California, Los Angeles